JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Thumbnail
View/Open
Publication Date
2021-02-15
ICR Author
Author
Paschalis, A
Welti, J
Neeb, AJ
Yuan, W
Figueiredo, I
Pereira, R
Ferreira, A
Riisnaes, R
Rodrigues, DN
Jimenez-Vacas, JM
Kim, S
Uo, T
Di Micco, P
Tumber, A
Islam, MS
Moesser, MA
Abboud, M
Kawamura, A
Gurel, B
Christova, R
Gil, VS
Buroni, L
Crespo, M
Miranda, S
Lambros, MB
Carreira, S
Tunariu, N
Alimonti, A
Al-Lazikani, B
Schofield, CJ
Plymate, SR
Sharp, A
de Bono, JS
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/4494
Collections
Licenseref URL
http://www.rioxx.net/licenses/all-rights-reserved
Version
VoR
Version of record
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
ANDROGEN-RECEPTOR
INCREASED SURVIVAL
GENE
PROTEIN
PROGRESSION
ABIRATERONE
VALIDATION
INHIBITORS
INTERACTS
ONTOLOGY
Research team
Computational Biology and Chemogenomics
Cancer Biomarkers
Prostate Cancer Targeted Therapy Group
Language
eng
Date accepted
2020-12-02
License start date
2021-02-15
Citation
CANCER RESEARCH, 2021, 81 (4), pp. 1087 - 1100 (14)
Publisher
AMER ASSOC CANCER RESEARCH